Ad-Hoc news provided via OAM Issuer Info Center (IIC) of OeKB (issuerinfo.oekb.at) are displayed.
Companies of the Vienna MTF/direct market are not obliged to submit their announcements to the OAM Issuer Info Center (IIC) of OeKB.
Marinomed Biotech honoured as Star of Innovation at European SME Awards
Published on 11/17/2021
Marinomed Biotech AG was honoured as ‘Star of Innovation' at the European Small and Mid-Cap Awards. CFO Pascal Schmidt attended the award ceremony in Portorož, Slovenia.
Listed since 2019 in the prime market segment at the Vienna Stock Exchange, the biopharmaceutical company has proven, that access to the capital markets is a turbo for research & development and essential to drive innovation.
The European Small and Mid-Cap Awards aim to promote best practices and encourage more small and medium-sized enterprises (SMEs) to access capital markets via IPOs.
This is a joint initiative of the European Commission, leading European securities exchanges and EuropeanIssuers.
#innovation #SMEs #IPO
More info about the stock: https://www.wienerborse.at/en/market-data/shares-others/quote/?ISIN=ATMARINOMED6&ID_NOTATION=244740791&cHash=099c0f25a925690c1be7077ca729849a
Stay updated on the Vienna Stock Exchange
➡️ Learn more: https://www.wienerborse.at/en/
➡️ Subscribe to our newsletters https://www.wienerborse.at/en/service/email-and-newsletter-service/
Follow us on social media and learn more
➡️ Twitter: https://twitter.com/wiener_boerse
➡️ LinkedIn: https://www.linkedin.com/company/wiener-borse-ag/
➡️ YouTube: https://www.youtube.com/channel/UCXqq_RYN8oNMEs1fUNefV-Q Date & Feature |
---|
No results found. |
The interviews have been conducted by Börsenradio.at and are provided in a prime version.